Free Case Evaluation
With Us

Tag Archives: Perigee

Uphold, Boston Scientific, still on the market

FDA Rules To Reclassify POP Vaginal Mesh as High Risk!

By Mesh Medical Device Newsdesk |

January 4, 2016 ~ An expert panel convened by the U.S. Food and Drug Administration (FDA) decided in September 2011 that mesh used to treat pelvic organ prolapse (POP) should be reclassified as high risk from its moderate risk (Class II) status. Today, the FDA announced POP mesh would finally be reclassified as a [continue reading…]

endo logo  two

Endo Offers $830 Million to Settle 20K AMS Pelvic Mesh Lawsuits

By Mesh Medical Device Newsdesk |

*This Just In* Late this afternoon, Endo Health Solutions announced it had reached an agreement with several law firms to settle in principle about 20,000 defective pelvic mesh lawsuits sold by its subsidiary American Medical Systems. Here is Endo’s news release. Here is Exhibit A: Resolution Framework: MR press release about the settlement [continue reading…]

AMS logo

Endo/ American Medical Systems Under Investigation for Transvaginal Mesh

By Mesh Medical Device Newsdesk |

Endo Health Solutions took over American Medical Systems (AMS) in 2011 for $2.9 billion and in doing do inherited roughly 22,000 transvaginal mesh lawsuits. That may have been a mistake. In its annual report released by the Securities and Exchange Commission Monday, Endo says it has received subpoenas from several states investigating its pelvic [continue reading…]

Dr. D. Veronikis

MND Interviews Dr. Veronikis: On Transvaginal Mesh, Injuries and Explants

By Mesh Medical Device Newsdesk |

The name of Dr. Dionysios Veronikis St. Louis is one that is increasingly heard among mesh-injured women.  Dr. Veronikis tells Mesh News Desk (MND) he now spends half of his time doing mesh removal surgeries, also known as explants, and although he still uses synthetic mesh on rare occasions, his surgical skills allow him [continue reading…]

AMS new sling RetroArc

FDA Approves New American Medical System Transvaginal Mesh Sling

By Mesh Medical Device Newsdesk |

American Medical Systems (AMS) has just received FDA clearance to market a new incontinence sling, according to a press release that appears in the Wall Street Journal. The RetroArc Retropubic Sling System received the Food the Drug Administration’s 510(k) clearance, a standard that does not require any clinical trials but relies on naming a [continue reading…]

judge mallet 200

AMS Granted Limited Discovery into Alleged "Scheme" in Transvaginal Mesh Litigation

By Mesh Medical Device Newsdesk |

On Friday, October 11, AMS, American Medical Systems, was given a limited green light to look into what it alleges could be a fraudulent “scheme” to  stack the deck in the plaintiff’s favor in the ongoing transvaginal mesh litigation. At the same time, those alleged in the questionable activities were granted protection from an [continue reading…]

Apogee for POP, AMS

Breaking News! Endo Settles Some AMS Vaginal Mesh Cases for $55 Million

By Mesh Medical Device Newsdesk |

June 21, 2013 ~ Endo Health Solutions Inc. unit has agreed to pay $54.5 million to settle some product liability lawsuits filed by women who were implanted with the Perigee, Apogee and Elevate transvaginal mesh. The women claim they were injured by the polypropylene mesh implants and call the transvaginal mesh a defective product. [continue reading…]

Family Tree of mesh products   600

Family Tree of Meshes from The Female Patient, April 2009

By Mesh Medical Device Newsdesk |

If you find it difficult to understand all of the different types of synthetic transvaginal mesh, this graphic from The Female Patient, April 2009 may help.

Monarc by AMS for SUI

American Medical Systems Files its Position Statement Laying Out its Strategy in Court in Defective Mesh Lawsuits

By Mesh Medical Device Newsdesk |

April 9, 2012 ~ On Friday, April 6, American Medical Systems Inc. (AMS) of Minnetonka, Minnesota filed its Position Statement with federal court in the Southern District of West Virginia laying out its strategy in its defense of its synthetic surgical mesh used to treat female conditions of pelvic organ prolapse (POP) and stress [continue reading…]

© 2016 Mesh Newsdesk. All rights reserved.
This news website is designed by